Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L De Backer

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
European Heart Journal. Quality of Care & Clinical Outcomes|March 20, 2023
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort studyMaxim Grymonprez, Mirko Petrovic, Tine L De Backer, et al.
Frontiers in Pharmacology|October 5, 2020
Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-AnalysisMaxim Grymonprez, Stephane Steurbaut, Tine L De Backer, et al.
Cardiovascular Drugs and Therapy|October 12, 2021
Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysisMaxim Grymonprez, Kevin Vanspranghe, Stephane Steurbaut, et al.
Thrombosis and Haemostasis|June 27, 2023
The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial FibrillationMaxim Grymonprez, Mirko Petrovic, Tine L De Backer, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 22, 2021
Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysisMaxim Grymonprez, Cynthia Simoens, Stephane Steurbaut, et al.
Cardiovascular Drugs and Therapy|January 11, 2021
Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation and (Morbid) Obesity or Low Body Weight: a Systematic Review and Meta-AnalysisMaxim Grymonprez, Tine L De Backer, Stephane Steurbaut, et al.
Frontiers in Pharmacology|February 23, 2023
Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort studyMaxim Grymonprez, Tine L De Backer, Xander Bertels, et al.
JBR-BTR : Organe De La Societe Royale Belge De Radiologie (SRBR) = Orgaan Van De Koninklijke Belgische Vereniging Voor Radiologie (KBVR)|January 30, 2003
The body packer syndromeA l De Backer, B De Keulenaer, K J Mortelé, et al.
Journal of Human Hypertension|August 17, 1999
Reversed day-night ambulatory blood pressure profile and blunted heart rate variability of unknown cause in a hypertensive patientT L De Backer, M L De Buyzere, F Colardyn, et al.
Clinical Cardiology|March 26, 2021
The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis on the obesity paradoxMaxim Grymonprez, Andreas Capiau, Tine L De Backer, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
European Heart Journal. Quality of Care & Clinical Outcomes|March 20, 2023
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort studyMaxim Grymonprez, Mirko Petrovic, Tine L De Backer, et al.
Frontiers in Pharmacology|October 5, 2020
Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-AnalysisMaxim Grymonprez, Stephane Steurbaut, Tine L De Backer, et al.
Cardiovascular Drugs and Therapy|October 12, 2021
Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysisMaxim Grymonprez, Kevin Vanspranghe, Stephane Steurbaut, et al.
Thrombosis and Haemostasis|June 27, 2023
The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial FibrillationMaxim Grymonprez, Mirko Petrovic, Tine L De Backer, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 22, 2021
Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysisMaxim Grymonprez, Cynthia Simoens, Stephane Steurbaut, et al.
Cardiovascular Drugs and Therapy|January 11, 2021
Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation and (Morbid) Obesity or Low Body Weight: a Systematic Review and Meta-AnalysisMaxim Grymonprez, Tine L De Backer, Stephane Steurbaut, et al.
Frontiers in Pharmacology|February 23, 2023
Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort studyMaxim Grymonprez, Tine L De Backer, Xander Bertels, et al.
JBR-BTR : Organe De La Societe Royale Belge De Radiologie (SRBR) = Orgaan Van De Koninklijke Belgische Vereniging Voor Radiologie (KBVR)|January 30, 2003
The body packer syndromeA l De Backer, B De Keulenaer, K J Mortelé, et al.
Journal of Human Hypertension|August 17, 1999
Reversed day-night ambulatory blood pressure profile and blunted heart rate variability of unknown cause in a hypertensive patientT L De Backer, M L De Buyzere, F Colardyn, et al.
Clinical Cardiology|March 26, 2021
The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis on the obesity paradoxMaxim Grymonprez, Andreas Capiau, Tine L De Backer, et al.
Pageof 4